Naluri

Naluri

Private
Singapore, Central SingaporeHealthcare & Life Scienceshttps://www.naluri.life

Last Round

Series B

Aug 12, 2025

Est. Valuation

$29M

Total Funding Raised

$19.85M

Company Overview

Naluri is a digital health service provider that offers a platform to help users manage both chronic diseases and mental health conditions. The company's platform combines behavioral science, data science, and digital design to provide personalized health coaching and psychological support for conditions such as diabetes, hypertension, heart disease, anxiety, and depression. It targets employers and insurers by providing solutions to help contain healthcare costs and improve employee productivity. The service is delivered through a mobile app that uses AI-augmented tools and human-led coaching to help individuals achieve and sustain better health outcomes.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Telemedicine, HR, Patient Engagement, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

employee wellness programdigital health platformchronic disease managementdigital mental healthcorporate wellness platformemployee assistance programmeEAPhealth coachingB2B health techdigital therapeuticsDTxtelehealthholistic carepreventative careoutcomes-based healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Naluri Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Naluri Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BAug 12, 2025
Series BJun 21, 2022
Series AJun 9, 2021
Pre SeedApr 24, 2020
Pre SeedJul 25, 2019
Seed
Jan 29, 2018

Key People

Founding team and executive leadership

Azran Osman-Rani

CEO And Co-Founder

Founding Team

Kenneth Koh

CEO, International, Chief Operating Officer

Executive Team

Tiffanie Ong

Chief Executive Officer - Naluri Health Solutions

Executive Team

Ahmad Shah Hafizan Hamidin

Chief Technology Officer

Executive Team

Naluri Investors

Notable investors and investment history

InvestorRounds
INP CapitalSeries B, Series A
Bertelsmann InvestmentsSeries B
Sumitomo Corporation Equity AsiaSeries A, Series B
Global Founders CapitalPre Seed
Palm Drive CapitalSeries B, Series A
KB InvestmentSeries A
Integra PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 13, 2026

    Appears to be working with the NHS for care delivery roles.

  • Aug 12, 2025

    $5M round completed

Naluri Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Naluri Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Naluri's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore, Central Singapore
Employee Range280
Year Founded2017
Last FundingAug 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.